EPIGENOMICS IN PUBLIC HEALTH

“๐““๐“๐“ ๐“ฒ๐“ผ๐“ท’๐“ฝ ๐“ป๐“ฎ๐“ช๐“ต๐“ต๐”‚ ๐“ต๐“ฒ๐“ด๐“ฎ ๐“ฝ๐“ฑ๐“ช๐“ฝ. ๐“˜๐“ฝ’๐“ผ ๐“ถ๐“ธ๐“ป๐“ฎ ๐“ต๐“ฒ๐“ด๐“ฎ ๐“ช ๐“ผ๐“ฌ๐“ป๐“ฒ๐“น๐“ฝ… ๐“ฒ๐“ญ๐“ฎ๐“ท๐“ฝ๐“ฒ๐“ฌ๐“ช๐“ต ๐“ผ๐“ฝ๐“ช๐“ป๐“ฝ๐“ฒ๐“ท๐“ฐ ๐“น๐“ธ๐“ฒ๐“ท๐“ฝ๐“ผ, ๐“ญ๐“ฒ๐“ฏ๐“ฏ๐“ฎ๐“ป๐“ฎ๐“ท๐“ฝ ๐“ธ๐“พ๐“ฝ๐“ฌ๐“ธ๐“ถ๐“ฎ๐“ผ.” - Nessa Carey

๐Ÿงฌ Epigenomics is reshaping how public health understands disease risk. Unlike genetic mutations, epigenomic changes alter gene expression without changing the DNA sequence, offering a powerful explanation for how environment, lifestyle, and social exposures become biologically embedded.

           ๐Ÿ”น From diet, chronic stress, pollution, toxins, and infections to early-life exposures, these influences can modify DNA methylation, histone marks, and chromatin accessibility; ultimately affecting susceptibility to obesity, diabetes, cancer, cardiovascular disease, and neurodevelopmental disorders.

           ๐Ÿ”น Epigenomics is advancing public health by clarifying gene-environment interactions, improving early detection with biomarkers, enabling precision prevention, guiding exposure policies, and explaining lifelong as well as intergenerational disease risk.

           ๐Ÿ”น A major translational advantage is the use of epigenetic signatures as population-level risk indicators, enabling more targeted screening, prevention, and health promotion strategies (especially in vulnerable communities disproportionately affected by harmful exposures).

          ➡️ However, the promise of epigenomics must be matched by ethical safeguards: privacy, informed consent, equitable access, and representation of diverse populations remain central to preventing new forms of health disparity.

⚠️ In an Oystershell, epigenomics bridges biology, environment, and policy. Its greatest public health value lies in transforming disease prevention from reactive treatment to proactive, exposure-informed precision health.

Abubakar Abubakar ✍๐Ÿป

• Christensen BC, Marsit CJ. Epigenomics in environmental health. Environmental and Molecular Mutagenesis. 2011;52(1):8-22.

• Bakulski KM, Halladay A, Hu VW, Mill J, Fallin MD. Epigenetic research in neuropsychiatric disorders: the “tissue issue.” Current Behavioral Neuroscience Reports. 2016;3(3):264-274.

• Ladd-Acosta C, Fallin MD. The role of epigenetics in genetic and environmental epidemiology. Epigenomics. 2016;8(2):271-283.

• Taylor & Francis Online
Motsinger-Reif AA, et al. Gene-environment interactions within a precision environmental health framework. Cell Genomics. 2024;4(6).

#Epigenomics #PublicHealth #PrecisionPublicHealth #Genomics #EnvironmentalHealth #Biomarkers #HealthPolicy #PGT #IVF #NGS #CRISPR⚕️

Comments

Post a Comment

Popular posts from this blog

UNDERSTANDING ACMG GUIDELINES & CLINICAL CLASSIFICATION OF GENETIC VARIANTS

Image
“๐“๐“ธ ๐“ผ๐“ฒ๐“ท๐“ฐ๐“ต๐“ฎ ๐“ต๐“ช๐“ซ๐“ธ๐“ป๐“ช๐“ฝ๐“ธ๐“ป๐”‚ ๐“ฑ๐“ช๐“ผ ๐“ฎ๐“ท๐“ธ๐“พ๐“ฐ๐“ฑ ๐“ญ๐“ช๐“ฝ๐“ช; ๐“ฌ๐“ธ๐“ต๐“ต๐“ช๐“ซ๐“ธ๐“ป๐“ช๐“ฝ๐“ฒ๐“ฟ๐“ฎ ๐“ฌ๐“พ๐“ป๐“ช๐“ฝ๐“ฒ๐“ธ๐“ท ๐“ฒ๐“ผ ๐“ฝ๐“ฑ๐“ฎ ๐“ฏ๐“พ๐“ฝ๐“พ๐“ป๐“ฎ ๐“ธ๐“ฏ ๐“ฐ๐“ฎ๐“ท๐“ธ๐“ถ๐“ฒ๐“ฌ ๐“ถ๐“ฎ๐“ญ๐“ฒ๐“ฌ๐“ฒ๐“ท๐“ฎ.” - Professor Heidi Rehm ๐Ÿงฌ Genomic medicine has moved from discovery to daily clinical decision-making. At the center of this shift are the 2015 standards from the American College of Medical Genetics & Genomics (ACMG), which established a structured framework for interpreting sequence variants.    ๐Ÿ”น Genetic variants influence disease risk, diagnosis, prognosis, & therapeutic strategy. Without standardized interpretation, clinical decisions become inconsistent. The ACMG/AMP framework addresses this by integrating multiple evidence streams into five categories: 1. Pathogenic (Class 5) 2. Likely Pathogenic (Class 4) 3. Variant of Uncertain Significance [VUS] (Class 3) 4. Likely Benign (Class 2) 5. Benign (Class 1) This tiered system reduces interpretive subjectivity & improves reproducibility...
Read more

BALANCED TRANSLOCATION

Image
"AN EXCHANGE CAN HAPPEN WITHOUT A GAIN OR LOSS, YET IT MAY PRODUCE SOME UNEXPECTED SIDE EFFECTS" ๐Ÿงฌ Balanced translocation is a type of chromosomal rearrangement where two segments of chromosomes are exchanged without any loss or gain of genetic material. This results in a rearrangement of genetic material within the chromosomes without any significant disruption. Balanced translocations typically involve the exchange of segments between non-homologous chromosomes, meaning that the segments are exchanged between different pairs of chromosomes.          ๐Ÿ”น Individuals with balanced translocations often do not display any outward physical signs or symptoms, as the total amount of genetic material remains the same. However, balanced translocations can have implications for health and reproduction. In some cases, balanced translocations can lead to infertility, recurrent miscarriages, or the potential for offspring to inherit unbalanced translocations, which do invo...
Read more

ERYTHEMA INFECTIOSUM

Image
"YOU MADE IT THROUGH PANDEMICS, BUT THERE'S STILL A FIFTH DISEASE" ๐Ÿงฌ Erythema Infectiosum, also known as Fifth Disease, is a viral infection caused by parvovirus B19. It is most common in children but can affect people of all ages. The characteristic symptom of erythema infectiosum is a distinctive rash on the cheeks giving a "slapped cheek" appearance, followed by a lacy rash on the trunk and limbs.            ๐Ÿ”ฌDiagnosis of erythema infectiosum is usually based on the characteristic rash and a history of exposure to the virus. In some cases, blood tests may be done to confirm the presence of parvovirus B19 antibodies.            ๐Ÿ’Š Treatment for erythema infectiosum is usually symptomatic, as the infection typically resolves on its own. Rest, fluids, and over-the-counter pain relievers may be recommended to alleviate symptoms.            ๐Ÿ’‰ Preventing the spread of erythema infectios...
Read more